The jury determined that Paul Gill developed acute myeloid leukemia as a result of his exposure to ExxonMobil’s product, awarding $725 million in compensatory noneconomic damages for Gill, plus $500,000 to his wife for loss of consortium.
The jury determined that Paul Gill developed acute myeloid leukemia as a result of his exposure to ExxonMobil’s product, awarding $725 million in compensatory noneconomic damages for Gill, plus $500,000 to his wife for loss of consortium.
Leave a Reply